Question 1

What is the catalog number for Perakizumab (Anti-CTLA-8 / IL-17a)?

Accepted Answer

The catalog number for Perakizumab (Anti-CTLA-8 / IL-17a) is C00620-1mg*5.

Question 2

What sizes are available for Perakizumab (Anti-CTLA-8 / IL-17a)?

Accepted Answer

Perakizumab (Anti-CTLA-8 / IL-17a) is available in the following size(s): 5x 1mg.

Question 3

Is Perakizumab (Anti-CTLA-8 / IL-17a) in stock?

Accepted Answer

Perakizumab (Anti-CTLA-8 / IL-17a) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 5

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Question 6

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Perakizumab (Anti-CTLA-8 / IL-17a)

Product Specifications

CAS Number

Synonyms

Target

Applications

Additionnal Information

Storage Conditions

Frequently Asked Questions

Explore Other Products

CD45 / LCA (2B11 + PD7/26), CF740 conjugate, 0.1mg/mL

CD45RO (UCHL-1), CF594 conjugate, 0.1mg/mL

CD59 (heavy chain of Protectin) (BRA-10G), CF405S conjugate, 0.1mg/mL

CD16 (C16/1045), CF594 conjugate, 0.1mg/mL

CD47 (B6H12.2), CF647 conjugate, 0.1mg/mL

Cytokeratin, LMW (AE-1), CF647 conjugate, 0.1mg/mL